JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A3856 Tamibarotene

Summary: RARα agonist

insoluble in H2O; ≥13.35 mg/mL
A3888 Trelagliptin

Summary: DPP-4 inhibitor,long-acting and selective

≥11.6 mg/mL
A3891 Triptolide
5 Citation

Summary: IL-2/MMP-3/MMP7/MMP19 inhibitor

≥36 mg/mL
A3894 TTP 22
1 Citation

Target: CK2

Summary: CK2 inhibitor

insoluble in H2O; ≥16.5 mg/mL
A3895 TUG-770

Target: Free Fatty Acid Receptors

Summary: FFA1/GPR40 agonist

insoluble in H2O; ≥11.85 mg/mL
A3900 Umeclidinium bromide

Summary: MAChR antagonist

insoluble in H2O; insoluble in EtOH; ≥61.5 mg/mL
A3942 XMD17-109

Target: ERK

Summary: ERK-5 inhibitor

≥31.95 mg/mL
C3458 N,N'-Dicyclohexylurea

Summary: soluble epoxide hydrolase (sEH) inhibitor

insoluble in H2O; insoluble in EtOH; ≥4.53 mg/mL
C4125 Ethacrynic Acid

Summary: A loop diuretic that inhibits the Na⁺/K⁺/2Cl^- cotransporter (NKCC2)

insoluble in H2O; ≥30.37 mg/mL
A1004 Amyloid Precursor C-Terminal Peptide

Summary: For beta amyloid generation

≥189.6 mg/mL